2 Patents
- US115660762023Anti-csf1r Antibody and Anti-pd-1 Antibody Combination Therapy for Selected Cancers
Bristol-myers Squibb Company
0 cites - US115595832023Anti-csf1r Antibody and Agonistic Anti-cd40 Antibody Combination Therapy for Cancer
Five Prime Therapeutics, Inc.
0 cites